Environmental Fears Fuel Growth In Chemical Standards

The need for chemical standards is skyrocketing, as a health-conscious public clamors to learn exactly how many parts-per-billion of pesticides are in their veggies, PCBs in their fish, dioxins in their milk, antibiotics in their burgers, cholesterol in their blood, and drugs in their employees' urine. But like a diner unable to judge the quality of a French restaurant because she's never sampled the finest French cuisine, analytical chemists charged with the mounting demand to establish trace

Written byRicki Lewis
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Helping to meet this demand is the United States Department of Commerce's National Institute of Standards and Technology (NIST), and about 30 private vendors. For these vendors, a booming business in standard materials has emerged because NIST is unable to supply everything; moreover, not everyone needs the utmost precision that NIST applies.

The standards business has its share of controversy. Recently, the Environmental Protection Agency ceased giving away chemical standards for some of its pollution-monitoring tests. The termination of this giveaway program touched off a lawsuit by one vendor. The firm says its business was damaged when EPA cleaned out its stocks of standards and provided them for free to five other companies.

Standards Everywhere Until 1988 NIST, based in Gaithersburg, Md., was known as the National Bureau of Standards. Selling "standard reference materials," or SRMs, is part of its charge. These are materials whose physical or chemical properties are ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies